Methyllycaconitine

CAS : 21019-30-7

Ref. 3D-XM183142

Informations sur le produit

• Nom: Methyllycaconitine
• Synonymes: (1α,6β,14α,16β)-20-Ethyl-1,6,14,16-tetramethoxy-4-[[[2-[(3S)-3-methyl-2,5-dioxo-1-pyrrolidinyl]benzoyl]oxy]methyl]aconitane-7,8-diol, Aconitane-7,8-diol, 20-ethyl-1,6,14,16-tetramethoxy-4-(((2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl)oxy)methyl)-, (1alpha,4(S),6beta,14alpha,16beta)-, Aconitane-7,8-diol, 20-ethyl-1,6,14,16-tetramethoxy-4-[[[2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl]oxy]methyl]-, [1α,4(S),6β,14α,16β]-, Aconitane-7,8-diol, 20-ethyl-1,6,14,16-tetramethoxy-4-[[[2-[(3S)-3-methyl-2,5-dioxo-1-pyrrolidinyl]benzoyl]oxy]methyl]-, (1α,6β,14α,16β)-, Aconitane-7,8-diol, 20-ethyl-4-(((2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl)oxy)methyl)-1,6,14,16-tetramethoxy-, (1-alpha,4(S),6-beta,14-alpha,16-beta)-, Brn 0076234, Delartine, Delsemidine, Lycaconitine, methyl-, [(1alpha,6beta,10alpha,13xi,14alpha,16beta,17xi)-20-ethyl-7,8-dihydroxy-1,6,14,16-tetramethoxyaconitan-4-yl]methyl 2-[(3S)-3-methyl-2,5-dioxopyrrolidin-1-yl]benzoate, [(6Beta,14Alpha,16Beta,17Xi)-20-Ethyl-7,8-Dihydroxy-1,6,14,16-Tetramethoxyaconitan-4-Yl]Methyl 2-(3-Methyl-2,5-Dioxopyrrolidin-1-Yl)Benzoate, [(6Beta,7Beta,13Xi,16Beta)-20-Ethyl-7,8-Dihydroxy-1,6,14,16-Tetramethoxyaconitan-4-Yl]Methyl 2-(3-Methyl-2,5-Dioxopyrrolidin-1-Yl)Benzoate, 4-21-00-04589 (Beilstein Handbook Reference)

Description

Methyllycaconitine is a potent inhibitor of kinases, making it a valuable medicinal compound for the treatment of various diseases. It has been shown to induce apoptosis in tumor cells and inhibit the growth of cancer cells in humans. Methyllycaconitine is an analog of lycaconitine, which is a toxic alkaloid found in Chinese herbal medicine. This compound has anticancer properties that make it a promising candidate for the development of new cancer therapies. Its ability to selectively target protein kinases involved in cancer cell growth and survival makes it a valuable tool for cancer research and drug discovery. In addition, methyllycaconitine has shown potential as an inhibitor of urinary bladder contractions, making it useful for treating related disorders.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 682.8 g/mol
• Formule: C₃₇H₅₀N₂O₁₀
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder